1-2 of 2
Leanne Berkahn, MB ChB, FRACP
Close
Sort by
Journal Articles

Hodgkin Lymphoma In First Remission: Routine PET/CT Imaging Is Not Superior To Clinical Follow-Up For Patients Without Residual Mass: Results Of a Bi-National Study Including 368 Patients

Eldad J Dann, MD, Leanne Berkahn, MB ChB, FRACP, FRCPA, Tatiana Mashiach, MSc, Michael Frumer, Ariel Agur, Bridgett McDiarmid, MD, Rachel Bar-Shalom, MD, Ora B. Paltiel, MSc, FRCPC, Neta Goldschmidt, MD
Journal: Blood
Blood (2013) 122 (21): 2995.
https://doi.org/10.1182/blood.V122.21.2995.2995
Published: 2013
Journal Articles

A Randomised Dose De-Escalation Safety Study of Oral Fludarabine, ±Oral Cyclophosphamide and Intravenous Rituximab (OFOCIR) As First-Line Therapy of Fit Patients with Chronic Lymphocytic Leukaemia (CLL) Aged ≥65 Years – End of Recruitment Analysis of Response and Toxicity of the Australasian Leukaemia and Lymphoma Group (ALLG) and CLL Australian Research Consortium (CLLARC) CLL5 Study

Stephen P Mulligan, MBBS, PhD, FRACP, FRCPA, Devinder S Gill, MB ChB, MRCP (UK), FRCPath (Lond), Paul Turner, MBBS FRACP FRCPA, William E. P. Renwick, MBBS, FRACP, FRCPA, Rosemary Harrup, MB BS, FRACP, FRCPA, Maya Latimer, MBBS, FRACP, FRCPA, Naomi Mackinlay, MB BS, FRACP, FRCPA, Leanne Berkahn, MB ChB, FRACP, FRCPA, David Simpson, FRACP, FRCPA, MBChB, Philip Campbell, MBBS, FRACP, FRCPA, Campbell Tiley, MBBS, FRACP, FRCPA, Gavin Cull, MBBS, DM, FRACP, FRCPA, Marnie Collins, BCom, BSc(Hons), Paul Cortissos, Melanie Sulda, B.Sc, Ph.D., Giles Best, B.Sc., Ph.D., Bryone J Kuss, MBBS, PhD, FRCPA, FRACP
Journal: Blood
Blood (2012) 120 (21): 436.
https://doi.org/10.1182/blood.V120.21.436.436
Published: 2012